Mr. Almeida assumed the roles in January 2016 following more than three decades in the healthcare industry, according to a Baxter news release. Brent Shafer, the company’s former lead independent director, was appointed Baxter’s chair and interim CEO.
The company announced Mr. Almeida’s retirement less than a week after the company fully restored operations at its manufacturing plant in Marion, N.C. In late September, the facility — which was the nation’s largest manufacturer of intravenous and peritoneal dialysis solutions — suffered severe flooding from Hurricane Helene.
The site temporarily closed, and as Baxter worked on recovery efforts, health systems experienced a sudden dearth of IV fluid supply. Some hospitals and systems delayed elective and nonemergency procedures due to the shortage.
Mr. Almeida will serve in an advisory capacity through Oct. 31, according to Baxter. Board member Nancy Schlichting is now lead independent director, and the head of Baxter’s Medical Products & Therapies business segment, Heather Knight, has assumed the COO position.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
